HOME >> BIOLOGY >> NEWS
Chemoradioimmunotherapy for advanced breast cancer: hope for the future?

A successful, and novel, technique to kill metastatic breast cancer cells by circumventing their chemo- and radioresistant mechanisms was by presented by Dr. John Giannios, Head of Radiotherapeutic Cancer Research at the IASO Hospital, Athens, Greece at the 18th Annual Meeting of the European Association of Cancer Research today (Tuesday 6 July 2004).

Advanced breast cancer, with metastases to lung and bone, has a very poor prognosis and current treatment protocols for this stage of disease generally result in survival periods of less than two years. One of the reasons for this poor prognosis is that metastatic cancer cells are less responsive to treatment than primary tumour cells. This is partly caused by the fact that the normal cell death process (apoptosis) is repressed by the overexpression of oncogenes such as bcl-2, HER-2, Raf-1 and cdc25c (these oncogenes are expressed more strongly in metastatic tumour cells), which means that the cells fail to die following treatment with chemotherapy drugs and radiation therapy.

Using metastatic tumour tissue taken from a patient with advanced breast cancer, Dr. Giannios's team analysed the cells to determine if known oncogenes were being overexpressed. In addition to finding overexpression of the oncogenes bcl-2, HER-2, Raf-1 and cdc25c they also detected overexpression of DNMT1 (a DNA methyltransferase, involved in DNA replication during cell division, and implicated in cancer development) and they also detected methylation of BRCA1 promoter (a process implicated specifically in the development of breast cancer tumours).

The experimental treatment, termed 'chemoradioimmunotherapy', combined chemotherapy, radiation therapy and immunotherapy in one. The chemotherapy component consisted of vinorelbine-tartrate (a cytotoxic drug used in the treatment of breast (and other) cancers), the radiotherapy component was provided through the addition of high energy radioisotopes, whilst the immunotherapy as
'"/>

Contact: Stuart Bell
stuart@fecs.be
00-32-0-495-27-2838
Federation of European Cancer Societies
6-Jul-2004


Page: 1 2 3

Related biology news :

1. Drug combo effective in advanced breast cancer
2. New drug target and biomarker for advanced childhood cancer discovered
3. Launch of Ariadna to boost advanced space research in Europe
4. Scientists develop advanced sensors for biological agent detection
5. Illinois lands research center for advanced water purification
6. New study expands look at high-dose vitamin D with docetaxel for advanced prostate cancer patients
7. Dynamic brain atlas may help diagnose patients using advanced brain scans
8. Old drug shows promise for helping treat advanced lung cancer
9. Marimastat produces comparable survival rates to chemotherapy in some advanced pancreatic cancer patients
10. SGX signs agreement to build state-of the-art beamlines at advanced photon source
11. UNC opens first clinical trial of vaccine treatment for advanced breast cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/6/2019)... ... June 05, 2019 , ... Pelican BioThermal ... network station and service center in Mexico City, Mexico. Mexico is the second ... with more than $1.75 billion in pharmaceutical exports since 2015. The Mexico City ...
(Date:6/4/2019)... , ... June 04, 2019 , ... ... announced the appointment of Susan Murphy as the new President of Molecular Devices, ... by Molecular Devices’ parent company, Danaher Corporation. , Since joining Molecular Devices in ...
(Date:6/4/2019)... DIEGO (PRWEB) , ... June 04, 2019 , ... Lajollacooks4u ... of Fame recipients. The recognition, which honors hospitality excellence, is given only to businesses ... Certificate of Excellence for five consecutive years. , To qualify for the ...
Breaking Biology News(10 mins):
(Date:5/31/2019)... ... May 30, 2019 , ... Object Pharma, Inc., ... strategic acquisition of Metabiologics, Inc., a globally recognized leader in the production and ... commercialization rights to a full spectrum of botulinum neurotoxins, as well as a ...
(Date:5/21/2019)... ... May 21, 2019 , ... DuPont Nutrition & ... the inaugural Africa Brewing Conference dedicated to sharing brewing knowledge, strengthening relationships and ... which is supported through a partnership with “Ethiopia Invest”, will run through May ...
(Date:5/14/2019)... ... May 13, 2019 , ... ... leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries’ ... The redesigned website aims to improve LDA’s ability to communicate directly with the ...
(Date:5/7/2019)... ... May 06, 2019 , ... "The ... growing number of repositories being asked to store cellular products being used ... of contributors who are world leaders, who have shared their expertise in building ...
Breaking Biology Technology:
Cached News: